Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Japanese Drugmaker to Acquire U.S. Firm

by Jean-François Tremblay
July 20, 2009 | A version of this story appeared in Volume 87, Issue 29

Japan's Hisamitsu Pharmaceutical has offered to acquire Miami-based Noven Pharmaceuticals for $430 million. Both companies develop transdermal drug delivery systems, or patches, mostly focusing on women's health, central nervous system diseases, and pain relief. Hisamitsu already owns 5% of Noven and considers acquiring the firm a quick way to boost its U.S. presence. Employing 610 people, Noven recorded sales of $109 million in 2008. Hisamitsu mostly develops pain relief patches and skin treatments.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.